SOURCE: iSatori

iSatori

April 10, 2015 19:49 ET

iSatori Voluntarily Ceasing Distribution of MX-LS7™v2

GOLDEN, CO--(Marketwired - April 10, 2015) - iSatori, Inc. (OTCQB: IFIT), an emerging leader in the development and marketing of scientifically engineered nutritional supplements for healthier lifestyles, today announced the removal of the weight-loss supplement MX-LS7™ v2 from the supplement market, accelerating the previously planned deletion of the item. Although an ingredient in question, Acacia rigidula, only makes up a small percentage of the total MX-LS7™v2 formula and appears to be DSHEA compliant, out of precaution, iSatori is ceasing its distribution and sales of MX-LS7™v2.

"Customer health and safety are top concerns for us at iSatori, in alignment with our products," explains Stephen Adelé, Chief Executive Officer of iSatori. "That's why we've performed rigorous clinical studies on the great majority of our products and thoroughly investigated the safety and research behind each and every ingredient of all of our products -- to ensure they are both safe and effective. When developing products, we perform our due diligence on chosen ingredients, and we obtain the professional opinions of our manufacturers and suppliers that the ingredients are plant derived [if botanical] and DSHEA compliant. The ingredient in question, which occurred in very small quantities in MX-LS7™v2, appears to be compliant, and the recent allegations against it are unproven. Nevertheless, out of an abundance of caution, we are ceasing distribution of this product. The ingredient in question, Acacia rigidula, is only in iSatori's MX-LS7™v2 (not the original MX-LS7), though it is in many other weight-loss supplements made by other companies. It constitutes less than 2% of the total MX-LS7™v2 formula."

Adelé continues, "Introduced in 2012, MX-LS7™v2 represents only 1.5% of our product sales. While we have not received any serious adverse event reports for the product since its introduction, the Company had already determined MX-LS7™v2 was at the tail end of its lifecycle, and we had been planning to wind down and delete the item." 

About iSatori, Inc.
iSatori is a consumer products firm that develops and sells scientifically engineered nutritional products through online marketing, Fortune 500 retailers, and thousands of retail stores around the world. The Company is headquartered in Golden, Colorado, and its common stock trades on the OTCQB under the symbol "IFIT." More information about the Company is available at www.isatori.com.

Forward-Looking Statements
Statements made in this news release relating to the Company's future sales, expenses, revenue, product developments, and all other statements except statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We have used the words "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," "will," "potential," and similar terms and phrases to identify forward-looking statements in this press release. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management's assumptions and the Company's future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially from those in the forward-looking statements, including, but not limited to, the timing and extent of changes in demand for the Company's products, the availability and price of ingredients necessary to manufacture such products, and the outcome of any current or future litigation regarding such products or similar products of competitors. Please see our Risk Factor disclosures included in our Registration Statement on Form S-1, as amended, initially filed with the Securities and Exchange Commission on April 30, 2013, and in subsequent filings with the Securities and Exchange Commission. All future written or oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the previous statements. The forward-looking statements herein speak as of the date of this press release. We undertake no obligation to update any information contained herein or to publicly release the results of any revisions to any forward-looking statements that may be made to reflect events or circumstances that occur, or that we become aware of, after the date of this press release.

Contact Information

  • Contacts:
    Self & Associates
    Trudy M. Self
    Investor Relations
    909.336.5685
    Email contact

    iSatori, Inc.
    Sue Mosebar
    Corporate Communications
    303.215.9174
    Email contact